Literature DB >> 24900322

The Implication of the First Agonist Bound Activated GPCR X-ray Structure on GPCR in Silico Modeling.

Christofer S Tautermann1, Alexander Pautsch1.   

Abstract

The very recently published first X-ray structure of the β2 adrenergic receptor in its active state hosting a small molecule (PDB ID: 3P0G) reveals a lot of information about the G-protein-coupled receptor (GPCR) activation process from a structural point of view. When compared to the inactive state crystal structure of β2, large differences are seen in the GPCR helical structure at the cytoplasmatic side, whereas very subtle changes occur at the ligand binding site. The observation that there are hardly any differences in the binding site of agonists and inverse agonists implies that in silico predictions of the efficacy of ligands will be very hard. This is illustrated by the example of an already published binding mode of a β2 agonist, which has been modeled into the inactive state X-ray structure of the β2 receptor. When comparing the modeled structure to the new activated X-ray structure, quantitative agreement of the binding mode is found, implying that the subtle changes between agonist binding to the activated state and inverse agonist binding to the inactive state can currently not be captured by standard in silico modeling methods.

Entities:  

Year:  2011        PMID: 24900322      PMCID: PMC4017970          DOI: 10.1021/ml100247s

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  19 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  PREDICT modeling and in-silico screening for G-protein coupled receptors.

Authors:  Sharon Shacham; Yael Marantz; Shay Bar-Haim; Ori Kalid; Dora Warshaviak; Noa Avisar; Boaz Inbal; Alexander Heifetz; Merav Fichman; Maya Topf; Zvi Naor; Silvia Noiman; Oren M Becker
Journal:  Proteins       Date:  2004-10-01

3.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

4.  Crystal structure of the ligand-free G-protein-coupled receptor opsin.

Authors:  Jung Hee Park; Patrick Scheerer; Klaus Peter Hofmann; Hui-Woog Choe; Oliver Peter Ernst
Journal:  Nature       Date:  2008-06-18       Impact factor: 49.962

5.  Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor.

Authors:  Supriyo Bhattacharya; Nagarajan Vaidehi
Journal:  J Am Chem Soc       Date:  2010-04-14       Impact factor: 15.419

6.  Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.

Authors:  Christoph Hoenke; Thierry Bouyssou; Christofer S Tautermann; Klaus Rudolf; Andreas Schnapp; Ingo Konetzki
Journal:  Bioorg Med Chem Lett       Date:  2009-10-12       Impact factor: 2.823

7.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

Review 8.  Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008.

Authors:  Mayako Michino; Enrique Abola; Charles L Brooks; J Scott Dixon; John Moult; Raymond C Stevens
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

9.  The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.

Authors:  Tony Warne; Rouslan Moukhametzianov; Jillian G Baker; Rony Nehmé; Patricia C Edwards; Andrew G W Leslie; Gebhard F X Schertler; Christopher G Tate
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

10.  Structure and function of an irreversible agonist-β(2) adrenoceptor complex.

Authors:  Daniel M Rosenbaum; Cheng Zhang; Joseph A Lyons; Ralph Holl; David Aragao; Daniel H Arlow; Søren G F Rasmussen; Hee-Jung Choi; Brian T Devree; Roger K Sunahara; Pil Seok Chae; Samuel H Gellman; Ron O Dror; David E Shaw; William I Weis; Martin Caffrey; Peter Gmeiner; Brian K Kobilka
Journal:  Nature       Date:  2011-01-13       Impact factor: 49.962

View more
  4 in total

1.  Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric site.

Authors:  Karen J Gregory; Elizabeth D Nguyen; Chrysa Malosh; Jeffrey L Mendenhall; Jessica Z Zic; Brittney S Bates; Meredith J Noetzel; Emma F Squire; Eric M Turner; Jerri M Rook; Kyle A Emmitte; Shaun R Stauffer; Craig W Lindsley; Jens Meiler; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2014-02-26       Impact factor: 4.418

2.  Pancreatic polypeptide is recognized by two hydrophobic domains of the human Y4 receptor binding pocket.

Authors:  Xavier Pedragosa-Badia; Gregory R Sliwoski; Elizabeth Dong Nguyen; Diana Lindner; Jan Stichel; Kristian W Kaufmann; Jens Meiler; Annette G Beck-Sickinger
Journal:  J Biol Chem       Date:  2013-12-27       Impact factor: 5.157

3.  Characterization of the Anopheles gambiae octopamine receptor and discovery of potential agonists and antagonists using a combined computational-experimental approach.

Authors:  Kevin W Kastner; Douglas A Shoue; Guillermina L Estiu; Julia Wolford; Megan F Fuerst; Lowell D Markley; Jesús A Izaguirre; Mary Ann McDowell
Journal:  Malar J       Date:  2014-11-18       Impact factor: 2.979

4.  G-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics Simulation.

Authors:  Osamu Ichikawa; Kazushi Fujimoto; Atsushi Yamada; Susumu Okazaki; Kazuto Yamazaki
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.